METHOD FOR DECREASING NEUROTOXICITY OF RADIOSENSITIZING AGENT SANASOL

FIELD: medicine, oncology. ^ SUBSTANCE: invention relates to therapy of malignant neoplasms. Method involves administration of ascorbic acid or ascorbic acid glycoside in the dose 50 mg/kg or water-soluble vitamin E in the dose 100 mg/kg. These preparations are administrated simultaneously with sana...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MALINOVSKAJA ELENA ANATOL'EVNA, SHISHKINA ANNA ALEKSANDROVNA, CHERDYNTSEVA NADEZHDA VIKTOROVNA, KAGIJA TSUTOMU V
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine, oncology. ^ SUBSTANCE: invention relates to therapy of malignant neoplasms. Method involves administration of ascorbic acid or ascorbic acid glycoside in the dose 50 mg/kg or water-soluble vitamin E in the dose 100 mg/kg. These preparations are administrated simultaneously with sanasol or 30 min before its administration. Method provides decreasing neurotoxicity based on antioxidant and immunostimulating properties of used preparations that are developed in the claimed administration regimen maximally. ^ EFFECT: improved method for decreasing neurotoxicity. ^ 3 cl, 18 tbl